Tandem Diabetes Care Inc, a leading provider in the realm of insulin delivery and diabetes technology, is revolutionizing diabetes management with its cutting-edge solutions.
SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced publication by the New England Journal of ...
It has been about a month since the last earnings report for Tandem Diabetes Care, Inc. (TNDM). Shares have added about 6.5% in that time frame, outperforming the S&P 500.
For the quarter ended December 2023, Tandem Diabetes Care, Inc. (TNDM) reported revenue of $196.8 million, down 10.8% over the same period last year. EPS came in at -$0.27, compared to -$0.01 in ...
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Q4 2021 Earnings Conference Call February 22, 2022 4:30 PM ETCompany ParticipantsSusan Morrison - EVP and CAOJohn ...
Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, plans to release its second quarter 2025 results after the financial markets close on ...
SAN DIEGO--(BUSINESS WIRE)-- Tandem Diabetes Care, Inc. (TNDM), a leading insulin delivery and diabetes technology company, plans to release its fourth quarter and full year 2024 results after the ...
Tandem Diabetes Care, Inc., a leading insulin delivery and diabetes technology company, today announced the appointment of Elizabeth Gasser as its new Executive Vice President, Strategy and ...
Tandem Diabetes Care, Inc. (TNDM) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation Provided by Business Wire Aug 14, 2025, 9:42:00 AM ...
TANDEM DIABETES CARE INC 競合他社・同業他社分析 - Industrial Applications and Services セクター
VAR_0__セクターの同業他社および競合他社に対するTANDEM DIABETES CARE INCの比較分析、AIを活用した予測および主要財務指標を掲載。
Our AI model demonstrates 47% historical accuracy for TNDM predictions, based on advanced machine learning algorithms trained on over 10 years of market data.
VAR_0__株価予測に影響を与える要因は何か?
当社の分析では、TANDEM DIABETES CARE INCの財務指標、Industrial Applications and Servicesセクターの動向、市場センチメント、テクニカル指標、業績データ、株価に影響を与えるマクロ経済要因を考慮しています。
2025年、TANDEM DIABETES CARE INCは良い投資先か?
AIの分析によると、TANDEM DIABETES CARE INCは次のようになる。 さまざまな市場シナリオの可能性. 投資の意思決定を行う前に、リスク許容度、投資スケジュール、ポートフォリオの分散を考慮してください。